SMAD2 and melanoma: Nelfinavir increased the amount of SMAD2 and consequently nuclear phospho-SMAD2 in melanoma cell lines in the absence of exogenous TGF-β (Figures 4A and 4B), and, importantly, this correlated with the reduction in PAX3 and MITF expression (Figure 4B).